Clinical Trial Update: A Nationwide Registry Study of Patients With Nonvalvular Atrial Fibrillation Initiating Oral Anticoagulation Therapies In The Early Period Following Apixaban Marketing In Denmark

View source ↗

Summary

A nationwide Danish registry study evaluated initiation of oral anticoagulation therapies in the early period after apixaban marketing in patients with nonvalvu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonvalvular Atrial Fibrillation

Drugs mentioned

• Eliquis (apixaban) (apixaban)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Anticoagulation | Status: COMPLETED